Published in Cell Immunol on October 10, 2001
Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol (2008) 2.85
Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci U S A (2005) 1.08
Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect Immun (2003) 1.02
Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. Clin Exp Immunol (2013) 0.83
Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer. Front Immunol (2013) 0.82
Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220+ double-negative T lymphocytes of autoimmune MRL/lpr mice. PLoS One (2012) 0.78
Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface. Mol Cancer (2014) 0.77
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med (1990) 2.82
Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods (1995) 2.35
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum (1993) 2.14
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07
Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood (1990) 2.02
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99
Viral infections in interferon-gamma receptor deficiency. J Pediatr (1999) 1.91
Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood (1994) 1.79
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73
Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59
Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood (1997) 1.58
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood (2001) 1.55
Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A (1997) 1.48
Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry (1997) 1.47
The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion (2010) 1.45
A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis. Arthritis Rheum (1998) 1.43
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42
Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol (1998) 1.41
Increased peripheral T lymphocyte activation in patients with karyotypically normal spontaneous premature ovarian failure. Fertil Steril (1991) 1.39
Comparison of two automated nephelometers. J Clin Lab Anal (1992) 1.39
Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis (1998) 1.35
Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation. J Immunol (1981) 1.34
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol (2001) 1.20
Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol (1991) 1.19
Interaction between perdeuterated dimyristoylphosphatidylcholine and low molecular weight pulmonary surfactant protein SP-C. Biochemistry (1990) 1.12
IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol (2001) 1.11
Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol (2001) 1.10
T and B lymphocyte subpopulations in children. Pediatrics (1975) 1.09
Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol (1998) 1.08
Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry (1996) 1.08
IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol (1988) 1.08
Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr (1996) 1.07
X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med (1980) 1.07
Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun (2001) 1.05
Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve (1997) 1.04
Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival. Pediatr Clin North Am (2000) 1.03
The interference of T cell activation by calcium channel blocking agents. J Immunol (1984) 1.01
Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol (1998) 1.00
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood (2000) 0.98
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis (1991) 0.98
Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production. J Immunol (1981) 0.97
Simultaneous modeling of phase and calorimetric behavior in an amphiphilic peptide/phospholipid model membrane. Biochemistry (1985) 0.97
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma (2001) 0.96
Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol (2000) 0.96
Normalization of antibody responsiveness in a patient with common variable hypogammaglobulinemia and HIV infection. N Engl J Med (1987) 0.96
Pulmonary surfactant protein SP-B interacts similarly with dipalmitoylphosphatidylglycerol and dipalmitoylphosphatidylcholine in phosphatidylcholine/phosphatidylglycerol mixtures. Biochemistry (1997) 0.94
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. Adv Exp Med Biol (1993) 0.92
Smoothed acyl chain orientational order parameter profiles in dimyristoylphosphatidylcholine-distearoylphosphatidylcholine mixtures: a 2H-NMR study. Biophys J (1995) 0.92
Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease. Pediatrics (1997) 0.91
Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. Am Rev Respir Dis (1991) 0.90
Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med (1991) 0.88
Production of human suppressor T cell hybridomas. J Immunol (1982) 0.88
Effect of glycosphingolipid fatty acid chain length on behavior in unsaturated phosphatidylcholine bilayers: a 2H NMR study. Biochemistry (1993) 0.88
Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med (1979) 0.88
Characterization of a soluble suppressor of human B cell immunoglobulin biosynthesis produced by a continuous human suppressor T cell line. J Exp Med (1981) 0.87
FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Immunol Res (2009) 0.87
Characterization of a new IL-6-dependent human B-lymphoma cell line in long term culture. Cytokine (1993) 0.87
Hydrostatic pressure-induced conformational changes in phosphatidylcholine headgroups: a 2H NMR study. Biophys J (1995) 0.86
Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest (1993) 0.86
The role of Fas and related death receptors in autoimmune and other disease states. J Allergy Clin Immunol (1999) 0.86
Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI) Ann Allergy Asthma Immunol (1996) 0.86
Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab (1990) 0.85
Studies on the interaction of human erythrocyte band 3 with membrane lipids using deuterium nuclear magnetic resonance and differential scanning calorimetry. Biochim Biophys Acta (1986) 0.84
Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis. J Immunol (1982) 0.84
Structural implications of a Val-->Glu mutation in transmembrane peptides from the EGF receptor. Biophys J (2001) 0.84
Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin Immunol (2000) 0.83
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clin Nephrol (1999) 0.83
Relationship between the unbinding and main transition temperatures of phospholipid bilayers under pressure. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.83
Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis. J Immunol (1983) 0.81
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects. Ann Rheum Dis (2003) 0.80
Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Transplant Proc (1991) 0.80
Immunological activities of recombinant interferon-alpha 2 and its A fragment. J Interferon Res (1987) 0.80
A pilot study of anti-CD5 ricin A chain immunoconjugate in systemic lupus erythematosus. J Rheumatol (1994) 0.80
A solid phase enzyme immunoassay (ELISA) for the detection and quantitation of anticardiolipin antibody. Am J Clin Pathol (1988) 0.79
Parasitic modulation of host immune mechanisms in schistosomiasis. Int Arch Allergy Appl Immunol (1987) 0.79
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res (1998) 0.78
Cellular immunity to cytomegalovirus in a patient following bone marrow transplantation. Transplantation (1978) 0.78
Application of lymphocyte immunophenotyping in selected diseases. Pathol Immunopathol Res (1988) 0.78
Effect of chain unsaturation on bilayer response to pressure. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.78
Effects of hydrostatic pressure on bilayer phase behavior and dynamics of dilauroylphosphatidylcholine. Biophys J (1996) 0.78
Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-gamma gene transfer. J Immunol (1996) 0.78
Serum antibody detected by fluorescent antibody test in patients with symptomatic Blastocystis hominis infection. Recenti Prog Med (1995) 0.77
Introduction to flow cytometry. Semin Hematol (2001) 0.77
Immunophenotyping. Semin Hematol (2001) 0.77
Identification of Pseudomonas aeruginosa DNA in a chorioretinal lesion associated with chronic granulomatous disease. J Clin Pathol (2008) 0.76
Isotype determination of antibodies. Curr Protoc Immunol (2001) 0.76
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. J Rheumatol (1998) 0.76
Effect of calcium on phospholipid interaction with pulmonary surfactant protein C. Biophys J (1997) 0.76
Immunoregulatory effects of C3 and its major cleavage fragments. Clin Immunol Immunopathol (1984) 0.75
Testing for chronic granulomatous disease. Lancet (1996) 0.75
Suppression of human T and B lymphocyte activation by Agaricus bisporus lectin. I. Suggestive evidence for a surface "suppressor" receptor in human lymphocytes. J Immunol (1981) 0.75